Send us Feedback

NeurogesX (NGSX)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

NGSX » Topics » SIGNATURES

This excerpt taken from the NGSX 8-K filed Nov 23, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:  

/s/    STEPHEN F. GHIGLIERI        

  Stephen F. Ghiglieri
  Chief Financial Officer

Date: November 23, 2009

 

3

This excerpt taken from the NGSX 8-K filed Nov 17, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:  

/S/    STEPHEN GHIGLIERI        

  Stephen Ghiglieri
  Chief Financial Officer

Date: November 17, 2009

 

3

This excerpt taken from the NGSX 8-K filed Nov 17, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:  

/S/    STEPHEN F. GHIGLIERI        

  Stephen F. Ghiglieri
  Chief Financial Officer

Date: November 17, 2009

 

3

This excerpt taken from the NGSX 8-K filed Nov 6, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEUROGESX, INC.
Date: November 6, 2009   By:  

/s/    STEPHEN F. GHIGLIERI        

    Stephen F. Ghiglieri
    Chief Financial Officer
This excerpt taken from the NGSX 8-K filed Aug 25, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:  

/s/    Stephen F. Ghiglieri

  Stephen F. Ghiglieri
  Chief Financial Officer

Date: August 25, 2009

 

3

This excerpt taken from the NGSX 8-K filed Aug 7, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: August 7, 2009     By:  

/s/    Stephen F. Ghiglieri

      Stephen F. Ghiglieri
      Chief Financial Officer
This excerpt taken from the NGSX 8-K filed Aug 6, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEUROGESX, INC.
By:   /s/ Stephen F. Ghiglieri
  Stephen F. Ghiglieri
  Chief Financial Officer

Date: August 6, 2009

This excerpt taken from the NGSX 8-K filed Jul 28, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:  

/s/    Stephen F. Ghiglieri

  Stephen F. Ghiglieri
  Chief Financial Officer

Date: July 28, 2009

 

3

This excerpt taken from the NGSX 8-K filed Jul 24, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEUROGESX, INC.
Date: July 24, 2009   By:  

/s/    Stephen F. Ghiglieri

    Stephen F. Ghiglieri
    Chief Financial Officer
This excerpt taken from the NGSX 8-K filed Jul 17, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:  

/s/    Stephen F. Ghiglieri

  Stephen F. Ghiglieri
  Chief Financial Officer

Date: July 17, 2009

 

3

EXHIBIT INDEX

 

Exhibit No.

   

Description

99.1

    Press Release dated July 17, 2009

 

4

This excerpt taken from the NGSX 8-K filed Jul 1, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date:   July 1, 2009     By:   /s/ Stephen F. Ghiglieri
        Stephen F. Ghiglieri
        Chief Financial Officer
This excerpt taken from the NGSX 8-K filed Jun 29, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:  

/s/    Stephen F. Ghiglieri

  Stephen F. Ghiglieri
  Chief Financial Officer

Date: June 29, 2009

 

3

This excerpt taken from the NGSX 8-K filed Jun 22, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: June 22, 2009     By:   /s/ Stephen F. Ghiglieri
     

Stephen F. Ghiglieri

Chief Financial Officer

This excerpt taken from the NGSX 8-K filed Jun 10, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: June 10, 2009     By:   /s/ Stephen F. Ghiglieri
        Stephen F. Ghiglieri
        Chief Financial Officer
This excerpt taken from the NGSX 8-K filed Jun 2, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEUROGESX, INC.

Date: June 2, 2009

   By:  

/s/    Stephen F. Ghiglieri

    Stephen F. Ghiglieri
    Chief Financial Officer
This excerpt taken from the NGSX 8-K filed May 22, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: May 22, 2009     By:   /s/ Stephen F. Ghiglieri
     

Stephen F. Ghiglieri

Chief Financial Officer

This excerpt taken from the NGSX 10-Q filed May 8, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: May 8, 2009    

NEUROGESX, INC.

(Registrant)

    /s/ Anthony A. DiTonno
   

Anthony A. DiTonno

President and Chief Executive Officer

(Principal Executive Officer)

   

/s/ Stephen F. Ghiglieri

   

Stephen F. Ghiglieri

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

42

Table of Contents
This excerpt taken from the NGSX 8-K filed May 7, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: May 7, 2009     By:   /s/ Stephen F. Ghiglieri
     

Stephen F. Ghiglieri

Chief Financial Officer

     
This excerpt taken from the NGSX 8-K filed Mar 20, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEUROGESX, INC.  
Date: March 20, 2009   By:  

/s/    Stephen F. Ghiglieri

  
    Stephen F. Ghiglieri  
    Chief Financial Officer  
This excerpt taken from the NGSX 8-K filed Mar 19, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

        NEUROGESX, INC.
Date: March 19, 2009     By:  

/s/    Stephen F. Ghiglieri

      Stephen F. Ghiglieri
      Chief Financial Officer
This excerpt taken from the NGSX 8-K filed Jan 20, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: January 20, 2009     By:   /s/ Stephen F. Ghiglieri
        Stephen F. Ghiglieri
        Chief Financial Officer
This excerpt taken from the NGSX 8-K filed Jan 7, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: January 7, 2009     By:   /s/ Stephen F. Ghiglieri
     

Stephen F. Ghiglieri

Chief Financial Officer

This excerpt taken from the NGSX 8-K filed Dec 23, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: December 23, 2008     By:   /s/ Stephen F. Ghiglieri
      Stephen F. Ghiglieri
      Chief Financial Officer
This excerpt taken from the NGSX 8-K filed Nov 7, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: November 7, 2008     By:   /s/ Stephen F. Ghiglieri
        Stephen F. Ghiglieri
        Chief Financial Officer
This excerpt taken from the NGSX 10-Q filed Nov 7, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: November 7, 2008   NEUROGESX, INC.
  (Registrant)
 

/s/ Anthony A. DiTonno

  Anthony A. DiTonno
  President and Chief Executive Officer
  (Principal Executive Officer)
 

/s/ Stephen F. Ghiglieri

  Stephen F. Ghiglieri
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

47

Table of Contents
This excerpt taken from the NGSX 8-K filed Oct 22, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: October 22, 2008     By:   /s/ Stephen F. Ghiglieri
     

Stephen F. Ghiglieri

Chief Financial Officer

This excerpt taken from the NGSX 8-K filed Aug 22, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: August 22, 2008     By:   /s/ Stephen F. Ghiglieri
        Stephen F. Ghiglieri
        Chief Financial Officer

This excerpt taken from the NGSX 10-Q filed Aug 14, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: August 14, 2008     NEUROGESX, INC.
    (Registrant)
      /s/ Anthony A. DiTonno
    Anthony A. DiTonno
    President and Chief Executive Officer
    (Principal Executive Officer)
      /s/ Stephen F. Ghiglieri
    Stephen F. Ghiglieri
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

49

Table of Contents
This excerpt taken from the NGSX 8-K filed Aug 13, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
  Date: August 13, 2008     By:   /s/ Stephen F. Ghiglieri
        Stephen F. Ghiglieri
        Chief Financial Officer
This excerpt taken from the NGSX 8-K filed Jun 4, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: June 4, 2008     By:    /s/ Stephen F. Ghiglieri
        Stephen F. Ghiglieri
        Chief Financial Officer
This excerpt taken from the NGSX 8-K filed May 15, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: May 15, 2008     By:   /s/ Stephen F. Ghiglieri
       

Stephen F. Ghiglieri

Chief Financial Officer

This excerpt taken from the NGSX 10-Q filed May 15, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: May 15, 2008    

NEUROGESX, INC.

(Registrant)

      /s/ Anthony A. DiTonno
   

Anthony A. DiTonno

President and Chief Executive Officer

(Principal Executive Officer)

      /s/ Stephen F. Ghiglieri
   

Stephen F. Ghiglieri

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

45

Table of Contents
This excerpt taken from the NGSX 8-K filed May 2, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NeurogesX, Inc.
By:   /s/ Stephen F. Ghiglieri
 

Stephen F. Ghiglieri

Chief Financial Officer

Date: May 2, 2008

 

3

This excerpt taken from the NGSX 8-K filed Mar 26, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date:   March 26, 2008     By:   /s/ Stephen F. Ghiglieri
        Stephen F. Ghiglieri
        Chief Financial Officer
This excerpt taken from the NGSX 10-K filed Mar 26, 2008.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

NEUROGESX, INC.
By:   /s/    ANTHONY A. DITONNO        
 

Anthony A. DiTonno

President, Chief Executive Officer and Director

Dated: March 26, 2008

This excerpt taken from the NGSX 8-K filed Feb 27, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:   /s/ Stephen Ghiglieri
  Stephen Ghiglieri
  Chief Financial Officer

Date: February 27, 2008

 

3

This excerpt taken from the NGSX 8-K filed Dec 28, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:  

/s/ Stephen Ghiglieri

  Stephen Ghiglieri
  Chief Financial Officer

Date: December 28, 2007

 

3

This excerpt taken from the NGSX 8-K filed Nov 14, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEUROGESX, INC.
Date: November 14, 2007     By:   /s/ Stephen F. Ghiglieri
        Stephen F. Ghiglieri
        Chief Financial Officer
This excerpt taken from the NGSX 10-Q filed Nov 14, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: November 14, 2007     NEUROGESX, INC.
    (Registrant)
      /s/ Anthony A. DiTonno
    Anthony A. DiTonno
   

President and Chief Executive Officer

(Principal Executive Officer)

      /s/ Stephen F. Ghiglieri
    Stephen F. Ghiglieri
   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

47

Table of Contents
This excerpt taken from the NGSX 8-K filed Nov 5, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.

By:   /s/ Stephen F. Ghiglieri
  Stephen F. Ghiglieri
  Chief Financial Officer

Date: November 5, 2007

 

3

This excerpt taken from the NGSX 8-K filed Oct 2, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEUROGESX, INC.
By:  

/s/ Anthony A. DiTonno

  Anthony A. DiTonno
  President and Chief Executive Officer

Date: October 2, 2007

 

4

EXCERPTS ON THIS PAGE:

8-K
Nov 23, 2009
8-K
Nov 17, 2009
8-K
Nov 17, 2009
8-K
Nov 6, 2009
8-K
Aug 25, 2009
8-K
Aug 7, 2009
8-K
Aug 6, 2009
8-K
Jul 28, 2009
8-K
Jul 24, 2009
8-K
Jul 17, 2009
8-K
Jul 1, 2009
8-K
Jun 29, 2009
8-K
Jun 22, 2009
8-K
Jun 10, 2009
8-K
Jun 2, 2009
8-K
May 22, 2009
10-Q
May 8, 2009
8-K
May 7, 2009
8-K
Mar 20, 2009
8-K
Mar 19, 2009
8-K
Jan 20, 2009
8-K
Jan 7, 2009
8-K
Dec 23, 2008
8-K
Nov 7, 2008
10-Q
Nov 7, 2008
8-K
Oct 22, 2008
8-K
Aug 22, 2008
10-Q
Aug 14, 2008
8-K
Aug 13, 2008
8-K
Jun 4, 2008
8-K
May 15, 2008
10-Q
May 15, 2008
8-K
May 2, 2008
8-K
Mar 26, 2008
10-K
Mar 26, 2008
8-K
Feb 27, 2008
8-K
Dec 28, 2007
8-K
Nov 14, 2007
10-Q
Nov 14, 2007
8-K
Nov 5, 2007
8-K
Oct 2, 2007

RELATED TOPICS for NGSX:

"SIGNATURES" elsewhere:

Adolor (ADLR)
Allos Therapeutics (ALTH)
Alexza Pharmaceuticals (ALXA)
Alexion Pharmaceuticals (ALXN)
Arena Pharmaceuticals (ARNA)
ArQule (ARQL)
Sarepta Therapeutics, Inc. (AVII)
AVANIR Pharmaceuticals (AVNR)
Cubist Pharmaceuticals (CBST)
CoreSite Realty Corp (COR)
Cardiome Pharma (CRME)
DepoMed (DEPO)
Durect (DRRX)
DUSA Pharmaceuticals (DUSA)
Dynavax Technologies (DVAX)
GENETIC TECHNOLOGIES (GENE)
Geron (GERN)
Genelabs Technologies (GNLB)
Isis Pharmaceuticals (ISIS)
Inspire Pharmaceuticals (ISPH)
Kendle International (KNDL)
Lannett Co (LCI)
Ligand Pharmaceuticals (LGND)
Medicines Company (MDCO)
NMT Medical (NMTI)
Neurogen (NRGN)
NitroMed (NTMD)
Orexigen Therapeutics (OREX)
PDL BioPharma (PDLI)
Pozen (POZN)
Prana Biotechnology (PRAN)
Pain Therapeutics (PTIE)
Pharmaxis (PXSL)
RELIV INTERNATIONAL INC (RELV)
SciClone Pharmaceuticals (SCLN)
Simcere Pharmaceutical Group (SCR)
Sunovion Pharmaceuticals Inc. (SEPR)
Santarus (SNTS)
Pernix Sleep, Inc. (SOMX)
Astex Pharmaceuticals, Inc (SUPG)
AmpliPhi Biosciences Corp (TGEN)
United Therapeutics (UTHR)
Pharmasset (VRUS)
XenoPort (XNPT)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki